Question 1

Does Merit Financial Group own IBRX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Merit Financial Group holds 47,916 shares of IBRX (Immunitybio), worth $419,505.

Question 2

How many shares of IBRX does Merit Financial Group own?

Accepted Answer

As of its Q2 2026 13F, Merit Financial Group holds 47,916 shares of IBRX (Immunitybio).

Question 3

What is Merit Financial Group's IBRX position worth?

Accepted Answer

As of its Q2 2026 13F, Merit Financial Group's IBRX position is worth $419,505.

Question 4

Is Merit Financial Group buying or selling IBRX?

Accepted Answer

In Q2 2026, Merit Financial Group increased its IBRX position by 3,351 shares (+7.5%).

Question 5

When did Merit Financial Group first buy IBRX?

Accepted Answer

Merit Financial Group first reported IBRX in its Q1 2023 13F and has listed it in 14 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	47,916	+7.5%	$419,505	0.0%	$8.76	26
2026-Q1	Increased	44,565	+0.6%	$341,814	0.0%	$7.67	24
2025-Q4	Decreased	44,308	-1.6%	$87,730	0.0%	$1.98	0
2025-Q3	Decreased	45,018	-8.4%	$110,744	0.0%	$2.46	0
2025-Q2	Increased	49,175	+11.2%	$129,822	0.0%	$2.64	25
2025-Q1	Increased	44,244	+1.0%	$133,174	0.0%	$3.01	22
2024-Q4	Increased	43,809	+0.0%	$112,151	0.0%	$2.56	22
2024-Q3	Decreased	43,800	-0.0%	$162,936	0.0%	$3.72	0